“…A total of 38 genes were represented in the network, with a number of focus genes with functions relating to transcription, growth and proliferation, and lipid metabolism lipid profile while consuming a diet enriched for Trans-fat/ HFCS is provided by the fact that the expression of lipogenic genes such as FAS and ACLY, together with major lipogenic transcription factor SREBP1C (Guillou et al 2008), were robustly downregulated in the livers of these animals. We also noted that the expression of genes involved in bile acid synthesis and efflux (Erickson et al 2003) for example Cyp7a1, ABCG8, ABCC3/MRP3, cholesterol uptake (LDLR), transport (ApoB), and de novo cholesterol synthesis (HMGCR, HMGCS1) were all reduced in cats fed the Trans-fat/HFCS diet, and this may explain why these cats did not exhibit increased levels of serum cholesterol and hepatic TAG compared to control.…”